1 Nasdaq 100 Stock to Consider Right Now and 2 Facing Headwinds

While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.

With rapid innovation comes rapid change, and StockStory is here to help you identify which Nasdaq 100 stocks are still worth your money. Keeping that in mind, here is one Nasdaq 100 stock that has huge potential and two that may struggle.

Two Stocks to Sell:

Starbucks (SBUX)

Market Cap: $103 billion

Started by three friends in Seattle’s historic Pike Place Market, Starbucks (NASDAQ:SBUX) is a globally-renowned coffeehouse chain that offers a wide selection of high-quality coffee, beverages, and food items.

Why Do We Steer Clear of SBUX?

1. Weak same-store sales trends over the past two years suggest there may be few opportunities in its core markets to open new restaurants
2. Estimated sales growth of 3.1% for the next 12 months implies demand will slow from its six-year trend
3. Efficiency has decreased over the last year as its operating margin fell by 7.1 percentage points

Starbucks is trading at $90.55 per share, or 38x forward P/E. Read our free research report to see why you should think twice about including SBUX in your portfolio.

Charter (CHTR)

Market Cap: $25.61 billion

Operating as Spectrum, Charter (NASDAQ:CHTR) is a leading telecommunications company offering cable television, high-speed internet, and voice services across the United States.

Why Is CHTR Risky?

1. Demand for its offerings was relatively low as its number of internet subscribers has underwhelmed
2. Free cash flow margin is not anticipated to grow over the next year
3. Rising returns on capital show management is making relatively better investments

At $198.46 per share, Charter trades at 4.9x forward P/E. If you’re considering CHTR for your portfolio, see our FREE research report to learn more.

One Stock to Watch:

Intuitive Surgical (ISRG)

Market Cap: $199.2 billion

Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ:ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties.

Why Is ISRG Interesting?

1. Products are seeing elevated demand as its system placement averaged 12.7% growth over the past two years
2. Sales outlook for the upcoming 12 months implies the business will stay on its desirable two-year growth trajectory
3. Earnings growth has trumped its peers over the last five years as its EPS has compounded at 20.9% annually

Intuitive Surgical’s stock price of $559.85 implies a valuation ratio of 61.6x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.